Safety and statin therapy - Reconsidering the risks and benefits

被引：47

作者：

Gotto, AM ^{[1
]}

机构：

[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2003年 / 163卷 / 06期

关键词：

D O I：

10.1001/archinte.163.6.657

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：657 / 659

页数：3

共 24 条

[1] Hepatotoxicity of commonly used drugs: Nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs [J].

Chitturi, S ;

George, J .

SEMINARS IN LIVER DISEASE, 2002, 22 (02) :169-183

[2]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3] Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Additional perspectives on tolerability of long-term treatment with lovastatin [J].

Downs, JR ;

Clearfield, M ;

Tyroler, HA ;

Whitney, EJ ;

Kruyer, W ;

Langendorfer, A ;

Zagrebelsky, V ;

Weis, S ;

Shapiro, DR ;

Beere, PA ;

Gotto, AM .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (09) :1074-1079

[4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[5]

Eriksen HR, 2002, SCAND J PSYCHOL, V43, P101, DOI 10.1111/1467-9450.00274

[6] Lipid-lowering drugs and risk of myopathy:: A population based follow-up study [J].

Gaist, D ;

Rodríguez, LAG ;

Huerta, C ;

Hallas, J ;

Sindrup, SH .

EPIDEMIOLOGY, 2001, 12 (05) :565-569

[7]

GEDDES JA, 1990, CMAJ, V142, P841

[8] Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors [J].

Hamelin, BA ;

Turgeon, J .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (01) :26-37

[9] Acute cholestatic hepatitis associated with pravastatin [J].

Hartleb, M ;

Rymarczyk, G ;

Januszewski, K .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (05) :1388-1390

[10] Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins) [J].

Igel, M ;

Sudhop, T ;

vonBergmann, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (05) :357-364

← 1 2 3 →